SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-023477
Filing Date
2024-03-18
Accepted
2024-03-18 16:01:43
Documents
15
Period of Report
2024-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201954-8k_augmedix.htm   iXBRL 8-K 39815
2 PRESS RELEASE DATED MARCH 18, 2024 ANNOUNCING FOURTH QUARTER AND FISCAL YEAR 202 ea020195401ex99-1_augmedix.htm EX-99.1 108270
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12415
  Complete submission text file 0001213900-24-023477.txt   356024

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE augx-20240318.xsd EX-101.SCH 3015
5 XBRL LABEL FILE augx-20240318_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE augx-20240318_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0201954-8k_augmedix_htm.xml XML 3728
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 24758917
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)